Depreciation in USD of INVIVO THERAPEUTICS HOLDINGS CORP. from Q2 2011 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Invivo Therapeutics Holdings Corp. quarterly/annual Depreciation history and growth rate from Q2 2011 to Q3 2023.
  • Invivo Therapeutics Holdings Corp. Depreciation for the quarter ending September 30, 2023 was $4K, a 71.4% decline year-over-year.
  • Invivo Therapeutics Holdings Corp. Depreciation for the twelve months ending September 30, 2023 was $53K, a 8.16% increase year-over-year.
  • Invivo Therapeutics Holdings Corp. annual Depreciation for 2022 was $60K, a 71.4% increase from 2021.
  • Invivo Therapeutics Holdings Corp. annual Depreciation for 2021 was $35K, a 20.7% increase from 2020.
  • Invivo Therapeutics Holdings Corp. annual Depreciation for 2020 was $29K, a 25.6% decline from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

INVIVO THERAPEUTICS HOLDINGS CORP. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $53K $4K -$10K -71.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $63K $10K -$3K -23.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $66K $19K +$6K +46.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $60K $20K +$11K +122% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 $49K $14K +$5K +55.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $44K $13K +$5K +62.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $39K $13K +$4K +44.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $35K $9K -$1K -10% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 $36K $9K +$4K +80% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $32K $8K +$1K +14.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $31K $9K +$2K +28.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $29K $10K +$2K +25% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-07
Q3 2020 $27K $5K -$4K -44.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $31K $7K -$3K -30% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $34K $7K -$5K -41.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $39K $8K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $9K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $10K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $12K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q3 2012 $6.21K $0 0% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-13
Q2 2012 $6.21K $0 0% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-13
Q3 2011 $6.21K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 $6.21K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13

INVIVO THERAPEUTICS HOLDINGS CORP. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $60K +$25K +71.4% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-01
2021 $35K +$6K +20.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 $29K -$10K -25.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-07
2019 $39K -$35K -47.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 $74K -$303K -80.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-20
2017 $377K -$159K -29.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $536K -$136K -20.2% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-12
2015 $672K -$63K -8.57% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 $735K +$734K +101560% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-10
2013 $723 -$366K -99.8% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-04
2012 $367K +$235K +178% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-11
2011 $132K Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.